Aptevo Therapeutics (APVO) Stock Insights
APVO$1.40+0.10 +7.69%
$3.06M
Market Cap
—
P/E
—
Forward P/E
—
Score
Aptevo Therapeutics (APVO) Stock Insights
APVO price $1.40 +0.10 +7.69%
- Ticker
- APVO
- Price
- $1.40
- Change
- +0.10 +7.69%
- Market cap ?
- $3.06M
- Sector
- Healthcare
- Industry
- Biotechnology
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company primarily focused on pioneering immunotherapeutic agents for a variety of cancer treatments across the United States. Its foremost investigational drug, APVO436, is a bispecific antibody crafted to engage T-cells, which is currently undergoing a Phase 1b clinical study for acute myeloid leukemia and myelodysplastic syndromes. Beyond its lead asset…
Insights · Dividends · Forecast · Financials · Learn